Last reviewed · How we verify
calcium threonate
At a glance
| Generic name | calcium threonate |
|---|---|
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
Common side effects
- Mild transient diarrhea
- Itching
- Transitory exanthema
- Feeling of swelling of entire body
Serious adverse events
- Polycythemia vera
- Allergic sensitization
Key clinical trials
- Supplement Combination on Stress and Sleep (NA)
- Effects of Magnesium L-Threonate on Sleep, Recovery, and Athletic Performance in Collegiate Athletes (NA)
- Magnesium-L-Threonate Improves Menopausal Symptoms (NA)
- Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty (PHASE4)
- Magnesium Supplementation in People With XMEN Syndrome (PHASE1,PHASE2)
- Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia (NA)
- Clinical Trial to Evaluate Magtein in Older Adults (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- calcium threonate CI brief — competitive landscape report
- calcium threonate updates RSS · CI watch RSS
- portfolio CI